Designed and executed comprehensive experimental plans (DoE) for pre-clinical studies, managing resources to successfully develop nutraceutical formulations targeting lung inflammation and allergic asthma.
Conducted *in vivo* and *in vitro* model studies using Ovalbumin (OVA) and Lipopolysaccharides (LPS), validating efficacy on murine models (Balb/c).
Performed cytotoxicity studies via ROS-NO-MTT assays in RAW 264.7 Macrophages, ensuring formulation safety and efficacy.
Evidenced formulation efficacy through diverse approaches including ELISA, Western blots, qRT-PCR, Histopathology (H&E Staining), and solubility/stability studies.
Mentored and assisted 2 MD(BAMS)-MSc thesis trainees in lab experiments and animal models, fostering team development.